Search
Now showing items 51-60 of 230
Characteristics of a cohort of Kenyans with neutralizing antibodies against HIV infection
(University of Nairobi, 2010)
Blood Safety in Kenya:Challenges in blood distribution and cold chain maintenance
(University of Nairobi,, 2012)
Oral squamous cell carcinoma in human immunodeficiency virus positive patients: clinicopathological audit
(University of Nairobi, 2012-03)
BACKGROUND:
Most human immunodeficiency virus positive patients now have a longer life expectancy, with the advent of highly active antiretroviral therapy. However, they are now at increased risk of developing a malignancy ...
Molecular Antiviral Susceptability Testing Of Seasonal Influenza A Virus Isolates Obtained In Kenya In The Year 2008-2009
(University of Nairobi., 2011)
Many pandemic Influenza A (H1N1) viruses that circulated in Kenya during the 2009-2010 Influenza seasons belonged to clade 7
(University of Nairobi., 2011)
Impact of Sulphur amino acid (SAA) dietary deficiency on nervous system response to cyanogenic intoxication
(University of Nairobi, 2011)
Multiple human papillomavirus infections and HIV seropositivity as risk factors for abnormal cervical cytology among female sex workers in Nairobi.
(2013)
We estimated type-specific prevalence of human papillomavirus (HPV) and examined risk factors for abnormal cervical cytology among 296 female sex workers from Nairobi, Kenya. Over half (54%) were infected with a high-risk ...
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
(2011)
Standard-dose HSV-2 suppressive therapy (acyclovir 400 mg twice daily) reduces plasma HIV-1 levels by 0.25-0.50 log(10) copies/mL. It is not known if higher doses might further suppress HIV-1 levels.
METHODS:
We enrolled ...